Market News & Trends
EPO Grants Hovione New Inhaler Patent
Hovione recently announced the European Patent Office has granted a patent for Hovione’s XCaps, a dry powder inhaler (DPI). XCaps addresses a pulmonary inhalation market…
Catalent Appoints Appoints New Asia Pacific President
Catalent Pharma Solutions recently announced it has named David Heyens in the new role of President of Catalent Asia Pacific. Reporting directly to Catalent’s President…
Amicus Therapeutics & Biogen Idec to Collaborate
Amicus Therapeutics recently announced it has entered a collaboration with Biogen Idec (BIIB) to discover, develop, and commercialize novel small molecules for the treatment of…
Roche & Inovio Enter $422.5-Million Licensing Deal
Roche and Inovio Pharmaceuticals, Inc. recently announced they have entered into an exclusive worldwide license agreement to research, develop and commercialize Inovio's highly optimized, multi-antigen…
TesoRx & CoreRx Announce Lucrative Joint Venture
TesoRx Pharma, LLC and CoreRx, Inc. recently announced a manufacturing joint venture to produce TSX-002, a first-in-class oral testosterone drug targeting the $2.5-billion low testosterone…
Rani Therapeutics Secures Funding Led by Google Ventures
Rani Therapeutics recently announced it has closed its Series B round of funding, led by Google Ventures. InCube Ventures, a life sciences venture fund that…
Injectable Dose Formulations Highly Impact Global Pharmaceutical Contract Manufacturing Vendor Revenues
Cost benefits and pharmaceutical companies’ desire to focus on their core competencies has created an increasing need for outsourcing and spurred the global pharmaceutical contract…
Baxter International & Coherus Biosciences Sign $246-Million Pact
Baxter International Inc. and Coherus Biosciences, Inc. recently announced they have entered into an exclusive collaboration to develop and commercialize a biosimilar to etanercept for…
Endo Health Solutions Pays $225 Million for Boca Pharmacal
Endo Health Solutions recently announced that its Qualitest subsidiary has reached a definitive agreement to acquire privately held Boca Pharmacal, a specialty generics company, for…
FDA Approves Third Drug in BD Simplist Prefilled Injectable Line of Products
BD Rx Inc., a wholly owned subsidiary of leading global medical technology company BD (Becton, Dickinson and Company), recently announced the US FDA has approved…
Sangamo BioSciences to Acquire Biotechnology Company
Sangamo BioSciences, Inc. recently announced it signed a definitive agreement to acquire Ceregene, Inc., a privately held biotechnology company focused on developing adeno-associated virus (AAV)…
Frost & Sullivan: Competition Intensifies as Pharma Companies Race to Launch Type 2 Diabetes Drugs
The global pre-diabetes population is three times the size of the current diabetes patient population. A tremendous increase in the pandemic’s prevalence is in store,…
CRO Market Grows Significantly; BRIC Regions Represent Huge Untapped Opportunity
The total combined peer group revenue from Contract Research Organizations (CROs) increased by 10.2% year-to-year, from $12.4 billion in 2011 to $13.6 billion in 2012,…
Syndax Pharmaceuticals Receives $26.6 Million for Final Stage Push With Cancer Drug
Syndax Pharmaceuticals Inc., which is developing epigenetic therapies for treatment-resistant cancers, recently announced it has secured a $26.6 million Series B financing. Participating investors included…
Catalyst Pharmaceutical Partners Gets Breakthrough Therapy Designation, Stock Soars 41.55%
Catalyst Pharmaceutical Partners, Inc. recently announced its investigational product Firdapse (amifampridine phosphate) has received Breakthrough Therapy Designation by the US FDA for the symptomatic treatment…
Pfizer’s Lung Cancer Drug Rejected; Deemed Too Costly
Pfizer Ltd has expressed concern and disappointment that the final appraisal determination (FAD) from the National Institute of Health and Care Excellence (NICE) does not…
Fresenius Kabi Enters Joint Venture With PT Soho Global Health
Fresenius Kabi has formed a joint venture with PT Soho Global Health, a leading Indonesian pharmaceutical company, acquiring a 51% stake in its PT Ethica…
Adimab Partners With Celgene Corporation
Adimab, LLC recently announced a multi-target discovery collaboration with Celgene Corporation of Summit, NJ. Under terms of the agreement, Adimab will use its proprietary platform…
InSite Vision Announces Patent Issuance on Ophthalmic Delivery System
InSite Vision Incorporated recently announced the United States Patent and Trademark Office (USPTO) has issued US Patent No. 8,501,800 on the company’s DuraSite 2 next-generation…
Foamix Celebrates Receiving 20th US Patent
Foamix Ltd. recently announced the United States Patent and Trademark Office has granted US Patent No. 8,512,718, Pharmaceutical Composition For Topical Application, describing, inter alia,…
